Carregant...
A new model to predict response to direct-acting antiviral therapy in decompensated cirrhotics due to hepatitis C virus
AIM: of the study: Decompensated hepatitis C virus (HCV) cirrhosis is a difficult to treat cohort, and there is no gold standard predictor of response to direct-acting antiviral (DAA) therapy. We conducted this study to look for factors responsible for improvement in post-therapy status, i.e. attain...
Guardat en:
| Publicat a: | Clin Exp Hepatol |
|---|---|
| Autors principals: | , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Termedia Publishing House
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7592091/ https://ncbi.nlm.nih.gov/pubmed/33145432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceh.2020.99525 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|